SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BELLINI, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.628
AS - Asia 6.794
EU - Europa 4.598
SA - Sud America 1.087
AF - Africa 127
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 13
Totale 25.265
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.382
SG - Singapore 2.684
CN - Cina 2.026
IT - Italia 1.003
BR - Brasile 919
UA - Ucraina 795
DE - Germania 753
HK - Hong Kong 670
TR - Turchia 529
GB - Regno Unito 436
VN - Vietnam 406
PL - Polonia 396
FI - Finlandia 293
RU - Federazione Russa 231
SE - Svezia 224
CA - Canada 117
MX - Messico 106
ID - Indonesia 94
FR - Francia 90
IN - India 75
AR - Argentina 74
NL - Olanda 68
ZA - Sudafrica 63
JP - Giappone 54
BE - Belgio 49
BD - Bangladesh 46
ES - Italia 41
AT - Austria 39
CZ - Repubblica Ceca 38
EE - Estonia 36
IQ - Iraq 35
EC - Ecuador 24
LT - Lituania 23
IR - Iran 22
CO - Colombia 18
KR - Corea 17
PK - Pakistan 16
UZ - Uzbekistan 15
AU - Australia 14
AE - Emirati Arabi Uniti 12
MY - Malesia 12
BG - Bulgaria 11
MA - Marocco 11
PY - Paraguay 11
SA - Arabia Saudita 11
VE - Venezuela 11
CL - Cile 10
EG - Egitto 10
KE - Kenya 10
RO - Romania 10
UY - Uruguay 10
EU - Europa 9
SD - Sudan 9
IE - Irlanda 8
PE - Perù 8
AZ - Azerbaigian 7
IL - Israele 7
JM - Giamaica 7
NP - Nepal 6
TN - Tunisia 6
TW - Taiwan 6
AL - Albania 5
DK - Danimarca 5
DZ - Algeria 5
ET - Etiopia 5
GE - Georgia 5
KZ - Kazakistan 5
OM - Oman 5
PH - Filippine 5
PT - Portogallo 5
RS - Serbia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
GR - Grecia 4
KW - Kuwait 4
LV - Lettonia 4
MD - Moldavia 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BY - Bielorussia 3
CH - Svizzera 3
JO - Giordania 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
GD - Grenada 2
HR - Croazia 2
HU - Ungheria 2
LB - Libano 2
MK - Macedonia 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BH - Bahrain 1
Totale 25.249
Salva come PNG Salva come JPEG
Città #
Singapore 1.578
Woodbridge 1.184
Ashburn 1.075
Fairfield 986
Chandler 927
Jacksonville 883
Houston 708
Ann Arbor 684
Beijing 679
Santa Clara 664
Hong Kong 663
Wilmington 409
Warsaw 381
Seattle 361
Dallas 311
Izmir 311
Cambridge 299
Nanjing 255
Ferrara 236
Princeton 207
Los Angeles 202
Munich 185
Boardman 165
Ho Chi Minh City 129
Dearborn 123
Milan 113
New York 111
Nanchang 95
Shenyang 87
Hanoi 85
Shanghai 85
San Diego 77
São Paulo 77
Addison 74
Mexico City 69
Turku 66
Changsha 65
Tianjin 63
Jakarta 62
London 60
Bologna 55
Helsinki 53
Hebei 52
Bremen 50
Brussels 47
Tokyo 47
Jiaxing 46
Buffalo 45
Hefei 45
Brooklyn 44
Moscow 41
Rome 41
Chicago 40
Jinan 36
Montreal 36
Orem 36
Toronto 36
Brno 33
Norwalk 33
Johannesburg 32
Orange 32
Phoenix 32
Ningbo 31
Poplar 31
Boston 30
Chennai 30
Stockholm 30
Denver 29
San Francisco 29
Vienna 28
Curitiba 26
Rio de Janeiro 26
Redwood City 25
Guangzhou 24
Frankfurt am Main 23
Haiphong 22
Kunming 22
Atlanta 21
Mountain View 21
Ankara 20
Auburn Hills 20
Leawood 20
Augusta 19
Zhengzhou 19
Belo Horizonte 18
Düsseldorf 18
Manchester 18
San Mateo 18
The Dalles 18
Dong Ket 17
Falkenstein 16
Falls Church 16
Da Nang 15
Brasília 14
Charlotte 14
San Jose 14
Des Moines 13
Amsterdam 12
Campinas 12
Hải Dương 12
Totale 16.497
Salva come PNG Salva come JPEG
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 387
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 256
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 238
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 229
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 214
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 212
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 205
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 202
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 200
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 199
A rapid method for purification of myelin basic protein 198
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 194
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 191
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 187
Activation of the sendai virus fusion protein by receptor binding 182
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 182
Chimica Medica e propedeutica Biochimica 179
Evaluation of a possible role of oxidative stress in climacteric symptoms. 179
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 178
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 178
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 178
Activation of the Sendai virus fusion protein by receptor binding 175
Mutual communication of envelope glycoproteins of paramixoviruses 174
Transfusion of stored red blood cells in critically ill trauma patients: a retrospective study 172
HUMAN ASYMPTOMATIC LEISHMANIA INFANTUM INFECTION. NEW INSIGHTS IN PATIENTS WITH CHRONIC RHEUMATIC DISEASES TREATED WITH BIOLOGICAL AGENTS AND LIVING IN RURAL AREAS OF NORTHERN ITALY 170
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 169
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 166
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 163
null 163
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 163
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 163
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 162
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 159
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 159
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 158
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 155
Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor 155
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 155
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 154
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 153
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 153
Analisi della proteina basica della mielina nel liquor 152
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 152
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 151
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 151
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 151
A machine-learning based bio-psycho-social model for the prediction of non-obstructive and obstructive coronary artery disease 150
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 150
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 150
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 150
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 150
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 147
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 145
Le Metalloproteasi come potenziali marcatori biologici nella Sclerosi Multipla 144
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 144
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 143
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 142
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 141
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 141
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 140
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 140
A Real-Time PCR to Detect Leishmania Infantum DNA in Immunocompetent Patients with Chronic Inflammatory Rheumatisms Living in Rural Areas of Northern Italy and Treated with Biologic Drugs. 140
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 139
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 138
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 137
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 137
Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project 136
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 135
A catalytic tyrosine at the active site of sendai virus neuraminidase 134
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 134
Anomeric specificity of the neuraminidase from sendai virus 134
Biochemical study in adult population with stroke in Ferrara, Fabry disease 134
Evidence for multiple pairs of vicinal thiols in some proteins 133
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 132
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 131
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 130
6-fosfogluconato deidrogenasi da eritrociti umani: interazione con i coenzimi 128
null 128
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 128
The effect of inorganic phosphate on the stability of some enzymes 127
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 127
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 126
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 126
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 126
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 124
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 123
Half-site reactivity in 6-phosphogluconate dehydrogenase from human erythrocytes 123
Rilevanza delle forme attive delle gelatinasi nel monitoraggio dell'attività della Sclerosi multipla 123
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 123
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 122
Pain in head and neck cancer patients: The role of gender 122
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 121
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study 120
Preliminary cheracterization of recombinant hemagglutinin from Mumps virus 120
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 119
Caratterizzazione di una proteina del LCS che interagisce con la proteina basica della mielina 119
Domain structure of the hemagglutinin-neuraminidase from sendai virus 119
Biochemical characterization of the natural Cys386-FX variant: a new tool to investigate coagulation factor X functions? 117
Allosteric inhibition of the water-soluble C-terminal fragment of Sendai virus neuraminidase 116
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 115
Totale 15.509
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.552
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 579
Totale 125.131
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.447 0 0 0 0 0 225 118 267 60 328 332 117
2021/20221.794 79 175 70 62 90 101 51 92 65 183 179 647
2022/20232.132 230 161 54 264 358 297 88 201 244 33 126 76
2023/2024952 98 121 62 25 95 89 25 66 30 23 28 290
2024/20254.210 119 78 375 164 528 329 142 246 650 565 564 450
2025/20266.648 1.119 552 1.168 1.547 1.634 628 0 0 0 0 0 0
Totale 25.597